NCT03029325Recruiting

Boston Lung Cancer Study (Molecular and Genetic Analysis of Lung Cancer)

Massachusetts General Hospital

Start Date

6/1/1993

Completion Date

9/1/2028

Summary

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Detailed Description

Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: -cases: pathology proven primary lung cancer Exclusion Criteria: * younger than 18 years old

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Lung Cancer

Locations

Massachusetts General Hospital

Boston, Massachusetts 02114

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Coordinate outreach and marketing across multiple sites as one effort, plus study-site logistics and tech support.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.